FINWIRES · TerminalLIVE
FINWIRES

Nojima Attributable Net Income, Net Sales Jump in Fiscal Year 2026

By

-- Nojima's (TYO:7419) net income attributable to owners of the parent for fiscal year 2026 increased to 38.93 billion yen from 32.29 billion yen a year earlier.

The consumer electronics company's EPS increased to 125.16 yen from 106.50 yen a year ago, according to a Tokyo bourse filing on Thursday.

Meanwhile, net sales for the year ended March 31 jumped to 982.80 billion yen from 853.43 billion yen in the prior year.

In a separate disclosure, Nojima said its board determined a year-end dividend of 10 yen per share, payable June 5. The amount is higher than the 8 yen the company forecasted in January, but lower than the 25 yen from the year-ago period.

Looking into fiscal 2027, the company expects a 23.3% annual growth in attributable net income to 48 billion yen and a 1.7% jump in net sales to 1 trillion yen.

Related Articles

Mining & Metals

RBC Maintains Suncor Energy's Outperform Rating, C$100 Price Target

RBC Capital Markets on Wednesday reiterated Suncor Energy's (SU.TO) outperform rating and C$100 price target, with the bank noting the company delivered another quarter of "robust performance" punctuated by a "jumbo-sized" downstream pre-tax margin of $2 billion (including FIFO gains) in part driven by record refined product sales of 680,900 bbl/d.RBC's updated production outlook of 862,100 bbl/d, anchored by a $5.7 billion capital program, remains relatively unchanged."Suncor's first-quarter results reinforced our confidence that its culture of sustained high performance is taking deep root and enabling the company to be on the podium, come what may," RBC said. "We believe the ingredients are in place for the company to earn a premium relative valuation, conceivably over the next year," RBC added.Suncor is RBC's favorite integrated producer in Canada and is part of its Global Energy Best Ideas list.Suncor traded at $85.70 per share at last look Thursday on the Toronto Stock Exchange.Price: $85.70, Change: $-2.21, Percent Change: -2.51%

$SU.TO
Australia

RBC Capital Adjusts VSE Price Target to $240 From $220, Maintains Outperform Rating

VSE (VSEC) has an average rating of Buy and mean price target of $248.50, according to analysts polled by FactSet.Price: $206.85, Change: $-0.60, Percent Change: -0.29%

$VSEC
Australia

RBC Capital Adjusts United Therapeutics Price Target to $701 From $707, Maintains Outperform Rating

United Therapeutics (UTHR) has an average rating of buy and mean price target of $670.67, according to analysts polled by FactSet.Price: $585.63, Change: $-11.14, Percent Change: -1.87%

$UTHR